Relmada Therapeutics is a very successful clinical stage firm that develops therapies that deal with chronic pain. Relmada Therapeutics is respected in the United States because of its products. Just recently, the medical institution had to go to court. According to the company management, the US District Court of Nevada recently issued a restraining order and associate injunction order to Laidlaw and its principles.
The restraining order issued against the investment banking company is a way to stop the misleading information and other proxy materials being disseminated. According to a recent report, Mathew Eitner and James Ahern, the two principles from the investment company received the court orders.
The U.S District Court gave the injunction to the principles and the investment banking firm after Relmada Therapeutics presented a case. According to the case, Laidlaw and its most important principles had previously disseminated information and other materials. Relmada Therapeutics believes that this information is false and also misleading to the public. The investment company was spreading the information to exercise full control over the Relmada Therapeutics. Relmada Therapeutics is very excited about the court decision.
Laidlaw Company is a very famous investment bank in the country. In the past, the company signed a contract to work as the finance institution for Relmada Therapeutics. This is not the first time the investment bank is getting in trouble. The company has had to go to court for similar cases in the past, mostly filed by unsatisfied clients. Not long ago, the court proved that the institution had violated some financial regulations. To make matters worse, more customers came up with the same claims. Laidlaw has had to deal with many regulatory sanctions, customer complaints, and monetary penalties. The new case by Relmada Therapeutics will only make matters worse, ruining the reputation of the company.